PDS Biotechnology reported a net loss of $7.6 million for Q3 2026, down from $9.0 million the previous year, reflecting reduced R&D expenses. The company advanced its lead cancer immunotherapy program PDS0301 and secured initial closing of a $22.3 million PIPE financing led by Nant Capital. New patents were issued for its Versamune® platform, supporting its cancer vaccine development. PDS Biotech also appointed new board members with pharma expertise and highlighted ongoing clinical trials targeting solid tumors, aiming to transform cancer treatment.
PDS Biotechnology's Q3 2026 financial results provide context for readers following health-sector stocks. As of Nov 13, 2026 19:41 WIB, out of 150 priced health-sector US stocks tradable on Pluang, 99 rose and 43 fell. Notable movers include CTXR at USD 0.51 with a 1-day change of -4.21% and Pluang order activity showing 84% Sell / 16% Buy, Tango Therapeutics Inc. (TNGX) at USD 24.00 down 3.42%, and Baxter International Inc. (BAX) at USD 26.59 up 3.30% with 100% Sell orders.
Michelin has announced the total number of its voting rights and shares as of October 31, 2026. The company has 691,516,292 shares and 960,075,649 voting rights, considering 20,287,710 treasury shares. This disclosure complies with French regulations...
Michelin has disclosed the total number of voting rights and shares composing its capital as of October 31, 2026. The company reported 691,516,292 shares, with theoretical voting rights totaling 980,363,359 and exercisable voting rights at 960,075,64...
KeyBanc lowered its price target for YETI Holdings to $49, suggesting a 27.94% upside from the current $38.30 stock price. This follows YETI's reduction of its full-year adjusted sales growth forecast to about 6% from the previous 7-8%, citing consum...
Bernstein SocGen Group has reduced its price target for Applied Materials to $600, even though the company reported higher sales and profits in Q4 2026 driven by strong demand for semiconductor services, especially AI chips. Applied Materials posted ...
Boralex Inc. announced a private placement of $600 million Canadian dollars in green bonds, split into two series maturing in 2031 and 2036 with interest rates of 4.503% and 5.173%, respectively. This marks Boralex's first issuance of green corporate...
